Completed PHASE4 INTERVENTIONAL NCT00259168

Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?

Insulin Resistance and Postprandial Endothelial Function: Does Early Intervention Make a Difference?

Sponsor: Atheline Major-Pedersen

Conditions Impaired Fasting Glucose Insulin Resistance

Interventions Nateglinide

Updated 5 times since 2017 Last updated: Nov 29, 2018 Started: Jun 30, 2003 Primary completion: Mar 31, 2006 Completion: Mar 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Impaired Fasting Glucose and Insulin Resistance, this trial is completed. The trial is conducted by Atheline Major-Pedersen and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2017 — Jan 2019 [monthly]

Unknown Status PHASE4

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Atheline Major-Pedersen
Bayer
Novartis

Data source: Bispebjerg Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bispebjerg Bakke, Copenhagen, Denmark